These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19009277)

  • 1. In vivo study of HCV in mice with chimeric human livers.
    Kneteman NM; Toso C
    Methods Mol Biol; 2009; 510():383-99. PubMed ID: 19009277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus replication in mice with chimeric human livers.
    Mercer DF; Schiller DE; Elliott JF; Douglas DN; Hao C; Rinfret A; Addison WR; Fischer KP; Churchill TA; Lakey JR; Tyrrell DL; Kneteman NM
    Nat Med; 2001 Aug; 7(8):927-33. PubMed ID: 11479625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel HCV replication mouse model using human hepatocellular carcinoma xenografts.
    Guévin C; Lamarre A; Labonté P
    Antiviral Res; 2009 Oct; 84(1):14-22. PubMed ID: 19622372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro models for analysis of the hepatitis C virus life cycle.
    Aly HH; Shimotohno K; Hijikata M; Seya T
    Microbiol Immunol; 2012 Jan; 56(1):1-9. PubMed ID: 22145950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-human primate surrogate model of hepatitis C virus infection.
    Akari H; Iwasaki Y; Yoshida T; Iijima S
    Microbiol Immunol; 2009 Jan; 53(1):53-7. PubMed ID: 19161559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
    Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
    Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication of hepatitis C virus.
    Moradpour D; Penin F; Rice CM
    Nat Rev Microbiol; 2007 Jun; 5(6):453-63. PubMed ID: 17487147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental models for hepatitis C viral infection.
    Boonstra A; van der Laan LJ; Vanwolleghem T; Janssen HL
    Hepatology; 2009 Nov; 50(5):1646-55. PubMed ID: 19670425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV research and anti-HCV drug discovery: toward the next generation.
    Wakita T
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1196-9. PubMed ID: 17905463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.
    Gottwein JM; Bukh J
    Adv Virus Res; 2008; 71():51-133. PubMed ID: 18585527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal model for study of human hepatitis viruses.
    Chayama K; Hayes CN; Hiraga N; Abe H; Tsuge M; Imamura M
    J Gastroenterol Hepatol; 2011 Jan; 26(1):13-8. PubMed ID: 21175788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon.
    Hiraga N; Imamura M; Tsuge M; Noguchi C; Takahashi S; Iwao E; Fujimoto Y; Abe H; Maekawa T; Ochi H; Tateno C; Yoshizato K; Sakai A; Sakai Y; Honda M; Kaneko S; Wakita T; Chayama K
    FEBS Lett; 2007 May; 581(10):1983-7. PubMed ID: 17466983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studying HCV cell entry with HCV pseudoparticles (HCVpp).
    Bartosch B; Cosset FL
    Methods Mol Biol; 2009; 510():279-93. PubMed ID: 19009269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of inducible hepatitis C virus transgenic mouse lines.
    Ernst E; Schönig K; Bugert JJ; Bläker H; Pfaff E; Stremmel W; Encke J
    J Med Virol; 2007 Aug; 79(8):1103-12. PubMed ID: 17596832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.
    Meuleman P; Leroux-Roels G
    Antiviral Res; 2008 Dec; 80(3):231-8. PubMed ID: 18706933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle.
    Régeard M; Lepère C; Trotard M; Gripon P; Le Seyec J
    FEBS J; 2007 Sep; 274(18):4705-18. PubMed ID: 17824957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus virology and new treatment targets.
    Meier V; Ramadori G
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus (HCV) infection: a systemic disease.
    Craxì A; Laffi G; Zignego AL
    Mol Aspects Med; 2008; 29(1-2):85-95. PubMed ID: 18177700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
    Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
    Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A milestone for hepatitis C virus research: a virus generated in cell culture is fully viable in vivo.
    Bukh J; Purcell RH
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3500-1. PubMed ID: 16505349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.